Stay updated with breaking news from Bridge Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LONDON and RALEIGH, N.C., Nov. 08, 2023 -- Verona Pharma plc , announces that senior management will present a company overview at the following conferences in November 2023: Jefferies London...
US FDA accepted NDA filing for ensifentrine for maintenance treatment of COPD PDUFA Target Action Date of June 26, 2024 Commercial launch preparations supported by strong balance sheet Conference...
CAMBRIDGE, Mass., Oct. 13, 2023 -- Intellia Therapeutics, Inc. , a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based...
LONDON and RALEIGH, N.C., Oct. 06, 2023 -- Verona Pharma plc , announces it will hold an Investor Update in New York City for investors and analysts on Wednesday, October 18, 2023, from 8:00 -...
PDUFA Target Action Date of June 26, 2024 Pooled analysis and subgroup data further support potential of ensifentrine, an investigational, novel, selective, dual inhibitor of PDE3 and PDE4 LONDON...